We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more…

Advances in Cardiovascular Risk Reduction


Get Directions

#var:page_name# cover

This one-day course will cover state-of-the-art management of patients with cardiovascular risk factors, focusing on prevention. The course will feature presentations on diabetes, obesity, hypertension, familial hypercholesterolemia and will also explore the role of liproprotein(a), platelets and PCSK9 in cardiovascular disease risk. The morning session will review the latest scientific and clinical advances in the management of diabetes, including topics such as the role of the RAGE receptor in diabetes-related complications, new glucose control treatments and their effects on cardiovascular disease risk. New insulin therapies and their potential for improving diabetic care and updated guidelines in diabetes management will be reviewed. The afternoon session includes a presentation on obesity as a cardiovascular risk factor, an update on hypertension and the latest research pertaining to cardiovascular markers including lipoprotein(a), PCSK9 and platelets. A presentation on familial hypercholesterolemia will highlight risk assessment strategies and treatment paradigms. Attendees will participate in a lunch case conference reviewing challenging cases in cardiovascular disease risk reduction.